Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4573866
Max Phase: Preclinical
Molecular Formula: C15H12N4O2
Molecular Weight: 280.29
Molecule Type: Unknown
Associated Items:
ID: ALA4573866
Max Phase: Preclinical
Molecular Formula: C15H12N4O2
Molecular Weight: 280.29
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Nc1ccc(-c2cn(-c3ccc(C(=O)O)cc3)nn2)cc1
Standard InChI: InChI=1S/C15H12N4O2/c16-12-5-1-10(2-6-12)14-9-19(18-17-14)13-7-3-11(4-8-13)15(20)21/h1-9H,16H2,(H,20,21)
Standard InChI Key: GOWLCEQWOYBWGX-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 280.29 | Molecular Weight (Monoisotopic): 280.0960 | AlogP: 2.21 | #Rotatable Bonds: 3 |
Polar Surface Area: 94.03 | Molecular Species: ACID | HBA: 5 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 4.53 | CX Basic pKa: 3.07 | CX LogP: 2.38 | CX LogD: -0.26 |
Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.72 | Np Likeness Score: -1.39 |
1. Kirsch P, Jakob V, Oberhausen K, Stein SC, Cucarro I, Schulz TF, Empting M.. (2019) Fragment-Based Discovery of a Qualified Hit Targeting the Latency-Associated Nuclear Antigen of the Oncogenic Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8., 62 (8): [PMID:30888817] [10.1021/acs.jmedchem.8b01827] |
Source(1):